Insufficient scRNA-seq data for expression of PTH2 at single-cell level.
Insufficient scRNA-seq data for expression of PTH2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 37% | 5.69 | 981 / 2642 | 0% | 0.01 | 3 / 705 |
| bladder | 14% | 0.29 | 3 / 21 | 1% | 0.02 | 7 / 504 |
| peripheral blood | 15% | 0.49 | 135 / 929 | 0% | 0 | 0 / 0 |
| ovary | 9% | 0.23 | 17 / 180 | 1% | 0.02 | 6 / 430 |
| uterus | 6% | 0.15 | 11 / 170 | 3% | 0.11 | 16 / 459 |
| heart | 10% | 0.30 | 82 / 861 | 0% | 0 | 0 / 0 |
| lung | 8% | 0.23 | 46 / 578 | 2% | 0.05 | 18 / 1155 |
| breast | 7% | 0.56 | 32 / 459 | 2% | 0.12 | 24 / 1118 |
| spleen | 8% | 0.26 | 20 / 241 | 0% | 0 | 0 / 0 |
| thymus | 8% | 0.25 | 51 / 653 | 0% | 0 | 0 / 605 |
| adipose | 7% | 0.20 | 82 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 5% | 0.18 | 13 / 258 | 2% | 0.10 | 4 / 230 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.44 | 3 / 45 |
| skin | 6% | 0.21 | 116 / 1809 | 0% | 0.00 | 1 / 472 |
| prostate | 6% | 0.16 | 14 / 245 | 0% | 0.00 | 1 / 502 |
| muscle | 6% | 0.17 | 47 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 6% | 0.18 | 78 / 1335 | 0% | 0 | 0 / 0 |
| kidney | 6% | 0.15 | 5 / 89 | 0% | 0.00 | 2 / 901 |
| intestine | 5% | 0.17 | 44 / 966 | 1% | 0.03 | 6 / 527 |
| liver | 5% | 0.19 | 12 / 226 | 0% | 0 | 0 / 406 |
| esophagus | 4% | 0.14 | 57 / 1445 | 1% | 0.03 | 2 / 183 |
| stomach | 3% | 0.10 | 12 / 359 | 1% | 0.01 | 2 / 286 |
| pancreas | 3% | 0.07 | 9 / 328 | 1% | 0.01 | 1 / 178 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007218 | Biological process | neuropeptide signaling pathway |
| GO_0005576 | Cellular component | extracellular region |
| Gene name | PTH2 |
| Protein name | Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Inositol polyphosphate 3-phosphatase) (Phosphatase and tensin homolog) Tuberoinfundibular peptide of 39 residues (TIP39) (Parathyroid hormone 2) |
| Synonyms | TIP39 TIPF39 |
| Description | FUNCTION: Plays a role as a potent and selective agonist of PTH2R resulting in adenyl cyclase activation and intracellular calcium levels elevation. Induces protein kinase C beta activation, recruitment of beta-arrestin and PTH2R internalization. May inhibit cell proliferation via its action on PTH2R activation. Neuropeptide which may also have a role in spermatogenesis. May activate nociceptors and nociceptive circuits. . |
| Accessions | Q96A98 ENST00000270631.2 O43460 |